Design of experiments

JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients

Retrieved on: 
Thursday, July 22, 2021

CPC is an ARO recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research.

Key Points: 
  • CPC is an ARO recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research.
  • CPC has over 30 years of experience in managing Phase 1 to 4 clinical trials and has provided services for over 150 clinical studies.
  • "CPC has an outstanding reputation for clinical trial management and we are thrilled to have their team on board for our upcoming Phase 2b trial," said Tony Isaac, President and Chief Executive Officer of JanOne.
  • JAN101 demonstrated positive results in a Phase 2a clinical trial and the Company is currently in preparations for Phase2btrials.

Plus Successfully Treats First Patient in Latest Dosing Cohort in ReSPECT™-GBM Trial

Retrieved on: 
Thursday, July 22, 2021

AUSTIN, Texas, July 22, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced the first patient in the eighth cohort of the Phase 1 dose escalation ReSPECT™-GBM clinical trial for recurrent glioblastoma (rGBM) has been successfully treated. The present cohort implements a 40% increase in volume (12.3 milliliters) and total radioactivity (31.2 millicuries) from the previous cohort.

Key Points: 
  • The present cohort implements a 40% increase in volume (12.3 milliliters) and total radioactivity (31.2 millicuries) from the previous cohort.
  • The ReSPECT-GBM Phase 1 clinical trial is progressing on schedule and with an acceptable safety profile, said Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics.
  • We plan to provide an update on the trial in the fourth quarter of 2021.
  • Twenty-two patients across eight dosing cohorts have been treated in the ReSPECT trial to date.

Global Sjogren's Syndrome Clinical Trial Pipeline Market Research Report 2021: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Sjogren'S Syndrome Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Sjogren'S Syndrome Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Sjogren's Syndrome Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Sjogren's Syndrome market.
  • It covers emerging therapies for Sjogren's Syndrome in active clinical development stages including early and late stage clinical trials.
  • The report provides Sjogren's Syndrome pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Gout Clinical Trial Pipeline Market research Report 2021: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Gout Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gout Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Gout Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Gout market.
  • It covers emerging therapies for Gout in active clinical development stages including early and late stage clinical trials.
  • The report provides Gout pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Celiac Disease Clinical Trial Pipeline Report 2021-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Celiac Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Celiac Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Celiac Disease Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Celiac Disease market.
  • It covers emerging therapies for Celiac Disease in active clinical development stages including early and late stage clinical trials.
  • The report provides Celiac Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Vitiligo Clinical Trial Pipeline Market Research Report 2021-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Vitiligo Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vitiligo Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Vitiligo Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Vitiligo market.
  • It covers emerging therapies for Vitiligo in active clinical development stages including early and late stage clinical trials.
  • The report provides Vitiligo pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Hereditary Angioedema Clinical Trial Pipeline Research Report-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Hereditary Angioedema Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hereditary Angioedema Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Hereditary Angioedema Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Hereditary Angioedema market.
  • It covers emerging therapies for Hereditary Angioedema in active clinical development stages including early and late stage clinical trials.
  • The report provides Hereditary Angioedema pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Urticaria Clinical Trial Pipeline Research Report 2021-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Urticaria Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Urticaria Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Urticaria Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Urticaria market.
  • It covers emerging therapies for Urticaria in active clinical development stages including early and late stage clinical trials.
  • The report provides Urticaria pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Rosacea Clinical Trial Pipeline Research Report 2021: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Rosacea Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Rosacea Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Rosacea Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Rosacea market.
  • It covers emerging therapies for Rosacea in active clinical development stages including early and late stage clinical trials.
  • The report provides Rosacea pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Graft Vs Host Disease Clinical Trial Pipeline Research Report 2021: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Graft Vs Host Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Graft Vs Host Disease Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Graft Vs Host Disease Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Graft Vs Host Disease market.
  • It covers emerging therapies for Graft Vs Host Disease in active clinical development stages including early and late stage clinical trials.
  • The report provides Graft Vs Host Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.